The vote in the European Parliament that passed the revamped Tobacco Products Directive will have some e-cigarette manufacturers contemplating the costly and often lengthy process of medicines licensing, in order to compete with larger firms able to afford the advantages that a marketing authorisation could bring.
Sign up to access to our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
